Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque

Virmani, 2006, Pathology of the vulnerable plaque, J Am Coll Cardiol, 47, C13, 10.1016/j.jacc.2005.10.065 Muller, 1989, Circadian variation and triggers of onset of acute cardiovascular disease, Circulation, 79, 733, 10.1161/01.CIR.79.4.733 Tomaniak, 2020, Vulnerable plaques and patients: state-of-the-art, Eur Heart J, 41, 2997, 10.1093/eurheartj/ehaa227 Motoyama, 2009, Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome, J Am Coll Cardiol, 54, 49, 10.1016/j.jacc.2009.02.068 Stone, 2011, A prospective natural-history study of coronary atherosclerosis [published correction appears in N Engl J Med 201124;365:2040], N Engl J Med, 364, 226, 10.1056/NEJMoa1002358 Calvert, 2011, Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study, J Am Coll Cardiol Img, 4, 894, 10.1016/j.jcmg.2011.05.005 Cheng, 2014, In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study, Eur Heart J, 35, 639, 10.1093/eurheartj/eht484 Waksman, 2019, Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study [published correction appears in Lancet 2019;394:1618], Lancet, 394, 1629, 10.1016/S0140-6736(19)31794-5 Prati, 2020, Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study [published correction appears in Eur Heart J 2020;41:393], Eur Heart J, 41, 383, 10.1093/eurheartj/ehz520 Moreno, 2010, Vulnerable plaque: definition, diagnosis, and treatment, Cardiol Clin, 28, 1, 10.1016/j.ccl.2009.09.008 Bourantas, 2015, Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data, EuroIntervention, 11, 746, 10.4244/EIJY14M10_06 Bourantas, 2013, Early detection and invasive passivation of future culprit lesions: a future potential or an unrealistic pursuit of chimeras?, Am Heart J, 165, 869, 10.1016/j.ahj.2013.02.015 Gomez-Lara, 2011, Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography, J Am Coll Cardiol Img, 4, 1271, 10.1016/j.jcin.2011.08.016 Bourantas, 2014, Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study, J Am Coll Cardiol Intv, 7, 315, 10.1016/j.jcin.2013.05.034 Pinilla-Echeverri, 2020, Nonculprit lesion plaque morphology in patients with ST-segment-elevation myocardial infarction: results from the COMPLETE Trial optical coherence tomography substudys, Circ Cardiovasc Interv, 13, 10.1161/CIRCINTERVENTIONS.119.008768 Komukai, 2014, Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study, J Am Coll Cardiol, 64, 2207, 10.1016/j.jacc.2014.08.045 Simsek, 2016, Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities, EuroIntervention, 11, 996 Bourantas, 2020, Shear stress estimated by quantitative coronary angiography predicts plaques prone to progress and cause events, J Am Coll Cardiol Img, 13, 2206, 10.1016/j.jcmg.2020.02.028 Stone, 2018, Role of low endothelial shear stress and plaque characteristics in the prediction of nonculprit major adverse cardiac events: the PROSPECT study, J Am Coll Cardiol Img, 11, 462, 10.1016/j.jcmg.2017.01.031 Stone, 2015, Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow), J Am Coll Cardiol Intv, 8, 927, 10.1016/j.jcin.2015.01.032 Stone, 2018, Eur Heart J, 39, 4112, 10.1093/eurheartj/ehy562 Knuuti, 2019, 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes, Eur Heart J, 41, 407, 10.1093/eurheartj/ehz425 Kolodgie, 2004, Pathologic assessment of the vulnerable human coronary plaque, Heart, 90, 1385, 10.1136/hrt.2004.041798 Cerrato, 2020, Revascularization deferral of non-culprit stenoses based on fractional flow reserve: one-year outcomes of 8579 patients, J Am Coll Cardiol Intv, 13, 1894, 10.1016/j.jcin.2020.05.024 Mehta, 2019, Complete revascularization with multivessel PCI for myocardial infarction, N Engl J Med, 381, 1411, 10.1056/NEJMoa1907775 McPherson, 2012, Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention, J Am Coll Cardiol Img, 5, 10.1016/j.jcmg.2012.01.005 Onuma, 2020, Randomized comparison between everolimus-eluting bioresorbable scaffold and metallic stent: multimodality imaging through 3 years, J Am Coll Cardiol Intv, 13, 116, 10.1016/j.jcin.2019.09.047 Wykrzykowska, 2017, Bioresorbable scaffolds versus metallic stents in routine PCI, N Engl J Med, 376, 2319, 10.1056/NEJMoa1614954 Stone, 2019, Time-varying outcomes with the absorb bioresorbable vascular scaffold during 5-year follow-up: a systematic meta-analysis and individual patient data pooled study, JAMA Cardiol, 4, 1261, 10.1001/jamacardio.2019.4101 Stone, 2017, Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials, J Am Coll Cardiol, 70, 2863, 10.1016/j.jacc.2017.09.1106 Tanaka, 2017, Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy, EuroIntervention, 12, 1730, 10.4244/EIJ-D-16-00247 Ortega-Paz, 2017, Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score, EuroIntervention, 12, 2110, 10.4244/EIJ-D-16-00974 Ali, 2018, Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds, Expert Rev Cardiovasc Ther, 16, 431, 10.1080/14779072.2018.1473034 Costantini, 2020, Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance, Catheter Cardiovasc Interv Verheye, 2007, Selective clearance of macrophages in atherosclerotic plaques by autophagy, J Am Coll Cardiol, 49, 706, 10.1016/j.jacc.2006.09.047